We are live on ! Find out more
PAHC icon

Phibro Animal Health

171 hedge funds and large institutions have $776M invested in Phibro Animal Health in 2018 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 62 increasing their positions, 61 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 17

20% more capital invested

Capital invested by funds: $646M → $776M (+$130M)

1.37% more ownership

Funds ownership: 98.46%99.82% (+1.4%)

1% more funds holding

Funds holding: 169171 (+2)

2% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 61

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
171
Holders Change
+2
Holders Change %
+1.18%
% of All Funds
3.92%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
22
Increased
62
Reduced
61
Closed
17
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$122M +$12.2M +330,614 +12%
Vanguard Group
2
Vanguard Group
Pennsylvania
$77.7M +$1.35M +36,538 +2%
FIM
3
Foresters Investment Management
New York
$48.7M +$44.4K +1,200 +0.1%
CVA
4
Ceredex Value Advisors
Florida
$45.2M +$42.1M +1,137,354 New
Invesco
5
Invesco
Georgia
$25.5M +$465K +12,567 +2%
CRCP
6
Copper Rock Capital Partners
Massachusetts
$24.9M -$183K -4,937 -0.8%
Renaissance Technologies
7
Renaissance Technologies
New York
$21.3M +$2.71M +73,304 +16%
State Street
8
State Street
Massachusetts
$21.1M -$399K -10,761 -2%
DIA
9
Denver Investment Advisors
Colorado
$20M -$1.01M -27,315 -5%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$19.8M +$1.32M +35,614 +8%
Goldman Sachs
11
Goldman Sachs
New York
$19.4M +$444K +12,002 +3%
Dimensional Fund Advisors
12
Dimensional Fund Advisors
Texas
$19.2M +$173K +4,674 +1%
Ameriprise
13
Ameriprise
Minnesota
$15.4M -$479K -12,921 -3%
TA
14
Teachers Advisors
New York
$14.7M +$658K +17,780 +5%
Northern Trust
15
Northern Trust
Illinois
$14.7M +$858K +23,172 +7%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$13.4M +$530K +14,314 +4%
Fuller & Thaler Asset Management
17
Fuller & Thaler Asset Management
California
$12.5M +$2.63M +70,900 +29%
AQR Capital Management
18
AQR Capital Management
Connecticut
$11.5M -$721K -19,468 -6%
EAM
19
Eagle Asset Management
Florida
$10M +$980K +26,452 +12%
Millennium Management
20
Millennium Management
New York
$9.81M -$6.4M -172,800 -41%
AL
21
AJO LP
Pennsylvania
$8.79M -$268K -7,249 -3%
GIP
22
Granite Investment Partners
California
$8.64M +$8.06M +217,670 New
Acadian Asset Management
23
Acadian Asset Management
Massachusetts
$8.52M +$1.18M +31,801 +17%
TCIM
24
TIAA CREF Investment Management
New York
$8.2M +$1.34M +36,110 +21%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$8.08M +$518K +13,988 +7%

PAHC Hedge Fund Activity: Q1 2018 in Review

171 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q1 2018, worth a combined $776M — up 20% from $646M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new PAHC positions and 17 closed out — a net gain of 5 holders — while 62 added to existing stakes and 61 trimmed.

The largest buyer was BlackRock, adding an estimated $12.2M. The largest seller was Thornburg Investment Management, cutting an estimated $12.5M.

  • 171 institutional investors held Phibro Animal Health (PAHC) as of Q1 2018, up from 169 in Q4 2017.
  • Funds reported $776M of Phibro Animal Health stock for Q1 2018, up 20% quarter-over-quarter.
  • 22 funds opened new Phibro Animal Health positions in Q1 2018 and 17 closed out, a net change of +5 holders.
  • The largest Phibro Animal Health buyer in Q1 2018 was BlackRock, an estimated $12.2M added.
  • The largest Phibro Animal Health seller in Q1 2018 was Thornburg Investment Management, an estimated $12.5M sold.

Based on aggregated 13F filings for Q1 2018.